Birdwatch Note
2023-10-21 04:11:41 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
2022年には欧米の政府機関や世界保健機関(WHO)などが相次いで、勧告や見解を発表。 イベルメクチンのメーカー元メルクも「臨床研究からのCOVID-19に対する潜在的な治療効果の科学的根拠はありません」「COVID-19疾患の患者における臨床活動または臨床的有効性に関する意味のある証拠はありません」などとする声明を発表。 https://www.yomiuri.co.jp/column/naruhodo/20220916-OYT8T50031/2/
Written by 085891369A32862A41AA5EFE10BD561E5DD6C924F7FF5A5DEF225BC5866D7C0C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1715355662597894423
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1715581595854504383
- noteId - 1715581595854504383
- participantId -
- noteAuthorParticipantId - 085891369A32862A41AA5EFE10BD561E5DD6C924F7FF5A5DEF225BC5866D7C0C Participant Details
- createdAtMillis - 1697861501073
- tweetId - 1715355662597894423
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 2022年には欧米の政府機関や世界保健機関(WHO)などが相次いで、勧告や見解を発表。 イベルメクチンのメーカー元メルクも「臨床研究からのCOVID-19に対する潜在的な治療効果の科学的根拠はありません」「COVID-19疾患の患者における臨床活動または臨床的有効性に関する意味のある証拠はありません」などとする声明を発表。 https://www.yomiuri.co.jp/column/naruhodo/20220916-OYT8T50031/2/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-10-21 04:11:41 UTC (1697861501073) |
1969-12-31 23:59:59 UTC (-1) |
2023-10-22 04:35:12 UTC (1697949312335) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-10-21 17:50:23 -0500 | Rating Details | |
2023-10-21 17:25:59 -0500 | Rating Details | |
2023-10-21 08:41:24 -0500 | Rating Details | |
2023-10-21 07:53:04 -0500 | Rating Details | |
2023-10-21 06:15:10 -0500 | Rating Details | |
2023-10-21 05:45:12 -0500 | Rating Details | |
2023-10-21 04:14:24 -0500 | Rating Details | |
2023-10-21 03:55:07 -0500 | Rating Details | |
2023-10-21 01:57:54 -0500 | Rating Details | |
2023-10-21 01:27:24 -0500 | Rating Details | |
2023-10-21 01:05:55 -0500 | Rating Details | |
2023-10-21 01:02:22 -0500 | Rating Details | |
2023-10-21 00:39:59 -0500 | Rating Details | |
2023-10-21 00:13:22 -0500 | Rating Details | |
2023-10-21 00:05:49 -0500 | Rating Details | |
2023-10-20 23:44:31 -0500 | Rating Details | |
2023-10-21 07:52:00 -0500 | Rating Details | |
2023-10-21 07:39:10 -0500 | Rating Details | |
2023-10-21 07:08:31 -0500 | Rating Details | |
2023-10-21 05:25:50 -0500 | Rating Details | |
2023-10-21 05:16:38 -0500 | Rating Details | |
2023-10-21 04:19:17 -0500 | Rating Details | |
2023-10-21 04:05:24 -0500 | Rating Details | |
2023-10-21 00:36:58 -0500 | Rating Details | |
2023-10-21 00:17:33 -0500 | Rating Details | |
2023-10-21 00:07:26 -0500 | Rating Details | |
2023-10-21 00:00:48 -0500 | Rating Details | |
2023-10-20 23:22:37 -0500 | Rating Details |